There are 108 resources available
Q&A and live discussion
Presenter: Anthony T.C. Chan
Session: Proffered Paper - Head & Neck cancer
Resources:
Webcast
Invited Discussant LBA40 and 911O
Presenter: Christian Simon
Session: Proffered Paper - Head & Neck cancer
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Anthony T.C. Chan
Session: Proffered Paper - Head & Neck cancer
Resources:
Webcast
LBA28 - A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial
Presenter: Mansoor Raza Mirza
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
806O - Radical hysterectomy in cervical cancer patients with intraoperatively detected positive lymph node: ABRAX multicentric retrospective cohort study (ENGOT-Cx3/CEEGOG CX2)
Presenter: David Cibula
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
LBA29 - Individualized starting dose of niraparib in Chinese patients with platinum-sensitive recurrent ovarian cancer (PSROC): A randomized, double-blind, placebo-controlled, phase III trial (NORA)
Presenter: Xiaohua Wu
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
LBA30 - INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
Presenter: Nicoletta Colombo
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
1214O - Neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC): Preliminary results from a multicenter study (IFCT-1601 IONESCO)
Presenter: Marie Wislez
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1215O - Neoadjuvant atezolizumab (A) for resectable non-small cell lung cancer (NSCLC): results from the phase II PRINCEPS trial.
Presenter: Benjamin Besse
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
LBA84 - Consolidation ipilimumab and nivolumab vs observation in limited stage SCLC after chemo-radiotherapy: Results from the ETOP/IFCT 4-12 STIMULI trial
Presenter: Solange Peters
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast